Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis

CD4(+)CD25(+) regulatory T cells (T reg cells) play a key role in controlling autoimmunity and inflammation. Therefore, therapeutic agents that are capable of elevating numbers or increasing effector functions of this T cell subset are highly desirable. In a previous report we showed that a superago...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyersdorf, Niklas, Gaupp, Stefanie, Balbach, Karen, Schmidt, Jens, Toyka, Klaus V., Lin, Chia-Huey, Hanke, Thomas, Hünig, Thomas, Kerkau, Thomas, Gold, Ralf
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2005
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213080/
https://www.ncbi.nlm.nih.gov/pubmed/16061730
http://dx.doi.org/10.1084/jem.20051060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213080/
https://www.ncbi.nlm.nih.gov/pubmed/16061730
http://dx.doi.org/10.1084/jem.20051060

Ejemplares similares